By Eric W. Dolan - PsyPost
A new meta-analysis published in the journal Psychopharmacology has found that individuals diagnosed with major depressive disorder tend to have Lower Levels of Glutathione in a specific area of the brain known as the occipital cortex. The findings add to growing evidence linking Depression to Oxidative Stress and suggest that Drain Antioxidants could play a role in understanding or potentially treating the disorder.
Major Depressive Disorder is a widespread mental health condition affecting hundreds of millions of people globally. It is associated with a wide range of symptoms, including persistent sadness, fatigue, loss of interest in previously enjoyable activities, and impaired cognitive and physical functioning.
Scientists have long investigated possible biological contributors to depression, including changes in neurotransmitter systems and immune activity. One area of increasing interest is the role of oxidative stress, which occurs when the body’s production of reactive molecules outpaces its antioxidant defenses.
Glutathione is the most abundant antioxidant found in the brain. It plays a central role in protecting brain cells from oxidative damage by neutralizing harmful molecules known as free radicals. When the balance between oxidative molecules and antioxidants is disrupted, cells can become damaged, potentially leading to or worsening a variety of diseases—including neuropsychiatric conditions like depression.…
